Recent MSK Discoveries & Advances

Memorial Sloan Kettering researchers are relentlessly exploring every aspect of cancer — from basic investigations of cells and molecules to clinical trials of new treatments and population-wide studies of the disease. While our core mission is to translate this knowledge into new strategies to control cancer, many of our investigators are also making scientific progress against other diseases and conditions.

Below are some examples of discoveries and advances that recently were made in our laboratories and clinics, and featured in our news stories.

and/or
378 News Items found
Image of As, Ts, Cs, and Gs representing genetic code
Announcement
Eight leading cancer centers are coming together to share genomic sequencing data, in the hope of making faster progress in curing cancer.
PET/CT scan of mouse prostate (displayed in green and orange).
In the Lab
An antibody that targets a protein specific to prostate cells can be used to image prostate cancer more clearly and indicate how well drugs are working.
Image of fireball-type explosion on black background.
In the Lab
Scientists have learned that a drug activates a form of highly inflammatory programmed cell death called pyroptosis — a discovery that sheds light on immune function.
Surgeon in scrubs operating on patient.
In the Clinic
Women who have reconstructive surgery after mastectomy and radiation for breast cancer are usually more satisfied with the results when their own tissue is used instead of implants.
Acute myeloid leukemia cells
Finding
Chemotherapy is a common treatment for acute myeloid leukemia, but patients often stop responding. Until now, not much was known about why.
Pouring white wine into a glass
Feature
Hear from our experts about a new study linking alcohol consumption and melanoma risk.
Bees in a hive
In the Lab
Findings about proteins called molecular chaperones are shedding new light on possible approaches to cancer treatment.
Chau Dang
Q&A
Medical oncologist Chau Dang explains that patients living with metastatic breast cancer have more treatment options than ever before.
Cell Therapy and Cell Engineering Facility
Snapshot
MSK physician-scientist Prasad Adusumilli is focused on developing more-effective immunotherapy approaches for treating tumors in the chest.
Illustration of CAR T cells with conveyor belts leading out of them carrying HVEM protein in tablet form.
In the Lab
A new immunotherapy approach involves engineering CAR T cells to produce proteins that treat lymphoma.